POM-V Prescription Required

Hexasol LA Solution for Injection for Cattle

Active ingredients: Flunixin, Oxytetracycline

Form

Injection

Species

Cattle

Manufacturer

Norbrook Laboratories Limited

VMD MA No.

02000/4152

What it's used for

Specifically formulated to provide initial anti-inflammatory for 24-36 hours and sustained anti-bacterial activity for 5-6 days following a single administ...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Flunixin + Oxytetracycline

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Hexasol LA Solution for Injection for Cattle — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Specifically formulated to provide initial anti-inflammatory for 24-36 hours and
sustained anti-bacterial activity for 5-6 days following a single administration.
Indicated primarily for the treatment of bovine respiratory disease associated
with
effect is required.
In addition, a wide range of organisms are known to be sensitive to
oxytetracycline, including
Staphylococcus aureus and certain mycoplasmas. The product may therefore
be of use in the treatment of disease in cattle caused by such organisms
where an anti-inflammatory and antipyretic effect is required.

Revised: June 2024
AN: 01955/2023

Indicated for deep intramuscular administration to cattle. The recommended
dosage is 1 ml per 10 kg bodyweight (equivalent to 2 mg/kg flunixin and 30
mg/kg oxytetracycline) on a single occasion.
Maximum volume per injection site: 15ml. If concurrent treatment is
administered use a separate injection site.
Additional therapy with an NSAID may be administered after 24 hours if
required.
Avoid the introduction of contamination.

Use is contraindicated in animals suffering from cardiac, hepatic or renal
disease, where there is a possibility of gastrointestinal ulceration or bleeding
or where there is hypersensitivity to the product.
Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a
potential risk of increased renal toxicity.
Do not administer other NSAIDs concurrently, or within 24 hours of each
other.
Concurrent use of potentially nephrotoxic drugs should be avoided.
Do not exceed the stated dose or duration of treatment.

The use of tetracyclines during the period of tooth and bone development,
including late pregnancy, may lead to discolouration.
Although the product is well tolerated, occasionally a local reaction of a
transient nature may be observed.
Hypersensitivity reactions (collapse) may occur very rarely. Such reactions
may evolve to a more severe condition (anaphylaxis), which may be life-
threatening.
The frequency of adverse reactions is defined using the following convention:
- very rare (less than 1 animal in 10,000 animals treated, including isolated
reports).

None known.

Special Precautions for use in animals:
Avoid intra-arterial injection.
Use in any animals less than 6 weeks of age or in aged animals may involve
additional risk. If such use cannot be avoided, animals may require a reduced
dosage and careful clinical management.
It is preferable that prostaglandin inhibiting drugs are not administered to
animals undergoing general anaesthesia until fully recovered.
Flunixin is toxic to avian scavengers. Do not administer to animals susceptible
to enter wild fauna food chain. In case of death or sacrifice of treated animals,
ensure that they are not made available to wild fauna.
Special precautions to be taken by the person administering the product
to the animals:
Avoid eye contact and direct contact with skin.
To avoid possible sensitisation reactions, avoid contact with skin. Gloves
should be worn during application.
Wash hands after use.
In the case of accidental contact with eyes, rinse immediately with plenty of
water and seek medical advice.
The product may cause reactions in sensitive individuals. If you have known
hypersensitivity for non-steroidal anti-inflammatory products, do not handle
the product. Reactions may be serious.
Avoid accidental self-injection.

Revised: June 2024
AN: 01955/2023

interaction:
Some NSAIDs may be highly bound to plasma proteins and compete with
other highly bound drugs which can lead to toxic effects.
Concurrent administration of potentially nephrotoxic drugs should be avoided.

Animals must not be slaughtered for human consumption during treatment.
Cattle may be slaughtered for human consumption only after 35 days from the
last treatment.
Not for use in cattle producing milk for human consumption.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.